Internal Medicine, Pulmonary Disease · Fort Wayne, IN
NPI
1891052064
Since 2012
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11104 Parkview Circle Dr Ste 410
Fort Wayne, IN, 46845
Phone (260) 266-5260
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
674 services
Medicare patients, 2024
311
Average age 73
Drug cost, 2024
$1.7M
1,784 prescriptions
Company payments, 2025
$50.66
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan J Bohle was code 99213 (office e&m - established), 132 times for 106 patients. In total Ryan J Bohle billed 674 services in 34 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 132 | 106 | $57.71 | $7,618 |
| 99233 Hospital E&M - Subsequent | Facility | 81 | 46 | $87.91 | $7,121 |
| 94726 Pulmonary Function Testing | Facility | 52 | 52 | $8.42 | $438 |
| 94729 Pulmonary Function Testing | Facility | 52 | 52 | $6.21 | $323 |
| 99204 Office E&M - New | Office | 32 | 32 | $112.87 | $3,612 |
| 94060 Pulmonary Function Testing | Facility | 31 | 31 | $7.57 | $235 |
| 94375 Pulmonary Function Testing | Facility | 30 | 30 | $9.72 | $291 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 29 | 28 | $12.30 | $357 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 25 | $58.52 | $1,638 |
| 94726 Pulmonary Function Testing | Office | 26 | 23 | $16.07 | $418 |
| 94729 Pulmonary Function Testing | Office | 25 | 22 | $14.51 | $363 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $94.68 | $2,272 |
| 99291 Critical Care E&M | Facility | 17 | 15 | $156.93 | $2,668 |
| 94375 Pulmonary Function Testing | Office | 14 | 12 | $15.71 | $220 |
| 94060 Pulmonary Function Testing | Office | 13 | 12 | $9.61 | $125 |
By year: 2022 $44K for 700 services; 2023 $47K for 802 services; 2024 $34K for 674 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ryan J Bohle prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 314 prescriptions and refills. In total Ryan J Bohle wrote 1,784 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 314 | 428 | 62 | $272K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 199 | 231 | 34 | $108K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 159 | 192 | 57 | $4,121 |
| Breo Ellipta Fluticasone/Vilanterol | 123 | 153 | 22 | $58K |
| Spiriva Respimat Tiotropium Bromide | 103 | 117 | 28 | $60K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 98 | 124 | 26 | $9,757 |
| Montelukast Sodium Generic | 95 | 237 | 28 | $720 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 88 | 117 | 24 | $56K |
| Prednisone Generic | 48 | 56 | 24 | $136 |
| Dupixent Pen Dupilumab | 46 | 46 | Under 11 | $182K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 45 | 53 | Under 11 | $32K |
| Fluticasone Propionate Generic | 40 | 104 | 25 | $422 |
| Symbicort Budesonide/Formoterol Fumarate | 40 | 86 | 18 | $19K |
| Incruse Ellipta Umeclidinium Bromide | 35 | 47 | Under 11 | $16K |
| Ofev Nintedanib Esylate | 32 | 32 | Under 11 | $449K |
Brand drugs: 1,362 claims; generic drugs: 422 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan J Bohle $50.66 ($50.66 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $18.26.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.